In a previous study, despite the small number of patients, they carefully suggested that the profile of a true super-responder to long-term anti-IL-5 biologics was an adult with a relatively short duration of eosinophilic asthma, without nasal polyps, chronic airflow limitation, or overweight. This evidence concerns the gene IL5 and nasal cavity polyp.